United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72241-053_750e2e2e-66d4-446d-9c90-cafcb3a4e926
- Product NDC
- 72241-053
- Form
- TABLET
- Composition / generic term
- Olanzapine
- Labeler
- Modavar Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230227
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (72241-053-05) · 72241-053-05
- 500 TABLET in 1 BOTTLE (72241-053-10) · 72241-053-10
- 1000 TABLET in 1 BOTTLE (72241-053-11) · 72241-053-11
- 30 TABLET in 1 BOTTLE (72241-053-22) · 72241-053-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →